Aceso Research Labs LLP
About Aceso Research Labs LLP
Data last updated:
Aceso Research Labs LLP is a limited liability partnership (LLP) based in Bangalore, Karnataka, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 19 May 2021 and has been in existence for over 5 years.
The LLP is registered with the Registrar of Companies (ROC), Bangalore, under LLPIN AAX-0730. Its GSTIN is 29ABVFA0086A1ZF (Karnataka).
The LLP has a total obligation of contribution of ₹1.4 Cr. It is led by designated partners Kranthi Chirala and Ravikanti Shailaja.
Its latest statement of accounts is for the year ended 31 March 2024. The registered office is at The Summit #1A 3rd Floor Echs Layout Judicial Colony Rmv 2nd Stage, Bangalore, Karnataka, India – 560094.
As per MCA filings, the LLP has open charges of ₹14.1 Cr on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressThe Summit #1A 3rd Floor Echs Layout Judicial Colony Rmv 2nd Stage, Bangalore, Karnataka, India – 560094
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Designated Partners of Aceso Research Labs LLP
Aceso Research Labs has 2 current designated partners and 4 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kranthi Chirala | Designated Partner | 18 Feb 2022 | 4 Years 7 Months | Current |
| Ravikanti Shailaja Also directs: DM Fincon Services LLP, Astal Laboratories Limited | Designated Partner | 18 Feb 2022 | 4 Years 7 Months | Current |
Financials of Aceso Research Labs LLP FY 2024 filings available
Financial Statement Summary of Aceso Research Labs LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Income and Expenditure | |||
| Turnover | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• |
| Assets and Liabilities | |||
| Partners' Contribution | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Aceso Research Labs LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| Net Profit Margin | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Aceso Research Labs are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings of Aceso Research Labs LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 May 2025 | Canara Bank | ₹9 Cr | Open |
| 25 Apr 2024 | Canara Bank | ₹5.1 Cr | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Aceso Research Labs LLP
Employment history and EPFO contributions of people linked to Aceso Research Labs.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Aceso Research Labs LLP
Aceso Research Labs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29ABVFA0086A1ZF | Karnataka | Active | 16 May 2022 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Aceso Research Labs LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Aceso Research Labs LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Aceso Research Labs LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Aceso Research Labs LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Aceso Research Labs LLP
Frequently Asked Questions about Aceso Research Labs LLP
Aceso Research Labs is an active limited liability partnership based in Bangalore, Karnataka, India. The LLP works in pharma contract r and d, within the pharma industry. It was incorporated on 19 May 2021 (5+ years old) and is registered under LLPIN AAX-0730.
Aceso Research Labs has 2 current designated partners:
- Kranthi Chirala - Designated Partner
- Ravikanti Shailaja - Designated Partner
The GSTIN of Aceso Research Labs is 29ABVFA0086A1ZF, registered in Karnataka.
The LLPIN (Limited Liability Partnership Identification Number) of Aceso Research Labs is AAX-0730. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Aceso Research Labs was incorporated on 19 May 2021, making it 5+ years old. It is registered with the Registrar of Companies, Bangalore.
The registered office of Aceso Research Labs is at The Summit #1A 3rd Floor Echs Layout Judicial Colony Rmv 2nd Stage, Bangalore, Karnataka, India – 560094.
The total obligation of contribution is ₹1.4 Cr.
Aceso Research Labs operates in the pharma industry, in the pharma contract r and d segment.
Aceso Research Labs has open charges of ₹14.1 Cr and no satisfied charges on record as per latest MCA filings.